CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,439,288 | +484.4% | 82,800 | +598.0% | 0.06% | +544.4% |
| Q1 2023 | $417,424 | -91.7% | 11,862 | -88.6% | 0.01% | -92.9% |
| Q3 2022 | $5,058,000 | +1370.3% | 104,400 | +1091.5% | 0.13% | +1300.0% |
| Q2 2022 | $344,000 | +42.1% | 8,762 | -28.3% | 0.01% | +12.5% |
| Q2 2021 | $242,000 | -18.8% | 12,217 | -4.8% | 0.01% | -27.3% |
| Q1 2021 | $298,000 | -37.5% | 12,833 | -44.0% | 0.01% | -38.9% |
| Q4 2020 | $477,000 | +266.9% | 22,936 | +101.0% | 0.02% | +50.0% |
| Q3 2019 | $130,000 | -17.2% | 11,411 | -39.7% | 0.01% | -14.3% |
| Q2 2018 | $157,000 | – | 18,928 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |